Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D Niederwieser

NF-κB/STAT5/miR-155 Network Targets PU.1 in FLT3-ITD-driven Acute Myeloid Leukemia

Leukemia

English

Impact of Graft-Versus-Host Disease After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

English

Monitoring of WT1 Expression in PB and CD34+ Donor Chimerism of BM Predicts Early Relapse in AML and MDS Patients After Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

English

Ten Years After the First Inspection of a Candidate European Centre, an EBMT Registry Analysis Suggests That Clinical Outcome Is Improved When Hematopoietic SCT Is Performed in a JACIE Accredited Program

Bone Marrow Transplantation

Transplantation

Hematology

2011

English

UVA (UVA-1) Therapy for the Treatment of Acute GVHD of the Skin

Bone Marrow Transplantation

Transplantation

Hematology

2010

English

Latin America: The Next Region for Haematopoietic Transplant Progress

Bone Marrow Transplantation

Transplantation

Hematology

2017

English

Latin America: The Next Region for Haematopoietic Transplant Progress

Bone Marrow Transplantation

Transplantation

Hematology

2017

English

Low-Dose ARAC, Donor Cells, and GM-CSF for Treatment of Recurrent Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation

English

Hematopoietic Stem Cell Transplantation for Hematological Malignancies in Europe

English

Treatment-Related Mortality and Graft-Versus-Leukemia Activity After Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Using Intensity-Reduced Conditioning

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D Niederwieser

NF-κB/STAT5/miR-155 Network Targets PU.1 in FLT3-ITD-driven Acute Myeloid Leukemia

Impact of Graft-Versus-Host Disease After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Monitoring of WT1 Expression in PB and CD34+ Donor Chimerism of BM Predicts Early Relapse in AML and MDS Patients After Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Ten Years After the First Inspection of a Candidate European Centre, an EBMT Registry Analysis Suggests That Clinical Outcome Is Improved When Hematopoietic SCT Is Performed in a JACIE Accredited Program

UVA (UVA-1) Therapy for the Treatment of Acute GVHD of the Skin

Latin America: The Next Region for Haematopoietic Transplant Progress

Latin America: The Next Region for Haematopoietic Transplant Progress

Low-Dose ARAC, Donor Cells, and GM-CSF for Treatment of Recurrent Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation for Hematological Malignancies in Europe

Treatment-Related Mortality and Graft-Versus-Leukemia Activity After Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Using Intensity-Reduced Conditioning